Review Article

Do Culture-Negative Periprosthetic Joint Infections Have a Worse Outcome Than Culture-Positive Periprosthetic Joint Infections? A Systematic Review and Meta-Analysis

Table 2

Data sheet for comparative analysis [1522].

AuthorLi H et al.Choi HR et al.Ibrahim MS et al.Huang R et al.Berbari EF et al.Malekzadeh D et al.Kim YH et al.Kim YH et al.

TitleTwo-stage revisions for culture-negative infected total knee arthroplasties: A five-year outcome in comparison with one-stage and two-stage revisions for culture-positive cases.Periprosthetic joint infection with negative culture results: Clinical characteristics and treatment outcome.Two-stage revision for the culture-negative infected total hip arthroplasty.Culture-negative periprosthetic joint infection does not preclude infection control.Culture-negative Prosthetic Joint Infection.Prior Use of Antimicrobial Therapy is a Risk Factor for Culture-negative Prosthetic Joint Infection.Comparison of infection control rates and clinical outcomes in culture-positive and culture-negative infected total-knee arthroplasty.The outcome of infected total knee arthroplasty: culture-positive versus culture-negative.

Year20172013201720122007201020152015

CountryNetherlandsUnited StatesUKUnited StatesUnited StatesUnited StatesKoreaKorea

LoEIIIIIIIIIIIIIIIIIIIIIIII

Study designRetrospectiveRetrospectiveProspectiveRetrospectiveRetrospectiveRetrospectiveRetrospectiveRetrospective

Study TypeCase-Control studyCase-Control studyCase-Control studyCase-Control studyCohort studyCase-Control studyCase-Control studyCase-Control study

Treatment interval2003-20142000-20092007-20122000-20071990-19991985-20002001-20081991-2008

Total number of cases129175-2958971413242191

Prevalence of CN cases %14.223-16.3710.542.126.7

Hip %-5010043.84550--

Knee %10050-56.25550100100

FU in months, median55.652604736-6056127.2127.2

Risk factors-(1) prior use of antibiotics
(2) referral from elsewhere
(3) age
(1) prior use of antibiotics (within 3 months)(1) prior use of antibiotics (in 64%)
(2) prolonged wound drainage after index arthroplasty (residual confounder)
--

Debridement n-11-1212185628

1-stage n358--

2-stage n1823503334564623

Permanent resection n---834--

Other therapy6--119--

Antibiotic treatment after diagnosis %Vancomycin 33 Vancomycin + Ceftriaxone 33 Others 34Vancomycin 70; Others 30-Vancomycin 81; Cephalosporins 10; Others 9Cephalosporins 82; Vancomycin 12; Others 6Cefazolin 69; Vancomycin 13; Others/None 18Vancomycin 85; Others 15Vancomycin 86; Others 14

Successful treatment in %88,98594---9595

Overall infection free survival rate %
1.) 3-year
2.) 5-year
--1.) -
2.) 94
73-1.) -
2.) 67
--

I&D infection free survival rate %
1.) 3-year
2.) 5-year
---501.) -
2.) 71
785761

2-Stage infection free survival rate %
1.) 3-year
2.) 5-year
1.) 75
2.) 95
--581.) -
2.) 94
1.) 87
2.) 79
8383

1-Stage infection free survival rate %
1.) 3-year
2.) 5-year
---100----

Resection arthroplasty infection free survival rate %
1.) 3-year
2.) 5-year
----1.) 511.) 49
2.) 43
--

OutcomeWith combined or broad-spectrum antibiotics, two-stage revision showed comparable outcome in satisfaction rates, reinfections rates and cumulative survival rates at 5-year Follow-up with CP PJI patients.The success rate of infection control was higher in the CN group, which suggests that CN may not necessarily be a negative prognostic factor for PJI.-The overall infection control rate was similar between CP and CN PJI cases (both 73%).The outcome of CN PJI is similar to the outcome of PJI due to known pathogens.The demographics and outcome of CP and CN PJI patients were similar (free of treatment failure at 2 years 79% and 75%).The infection control rates and clinical outcomes were not different between CP and CN groups (overall infection control rates 90% and 95%).Overall rates of infection control, successful treatment, and functional outcomes were not different between the CP and CN groups (overall infection control rates 90% and 95%).